SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-007478
Filing Date
2024-01-29
Accepted
2024-01-29 17:29:05
Documents
15
Period of Report
2024-01-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192424-8k_fresh2group.htm   iXBRL 8-K 30418
  Complete submission text file 0001213900-24-007478.txt   246138

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE fres-20240126.xsd EX-101.SCH 3863
3 XBRL DEFINITION FILE fres-20240126_def.xml EX-101.DEF 26768
4 XBRL LABEL FILE fres-20240126_lab.xml EX-101.LAB 37014
5 XBRL PRESENTATION FILE fres-20240126_pre.xml EX-101.PRE 25392
16 EXTRACTED XBRL INSTANCE DOCUMENT ea192424-8k_fresh2group_htm.xml XML 5476
Mailing Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108
Business Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108 1 917-397-6890
Fresh2 Group Ltd (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 8-K | Act: 34 | File No.: 001-39137 | Film No.: 24575033
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)